Michelle McCain
Houma, LANPI 1508867011
Payments from drug & device makers
$3,115in general payments, 2019–2025
Across 176 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$887
- AbbVie$494
- Pfizer$351
- UCB, Inc.$306
- Regeneron Healthcare Solutions, Inc.$194
- Johnson & Johnson$194
- plus $689 from 12 others
What the payments were for
- Food & beverage$3,02897%
- Education$873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 48 | $887 |
| AbbVie | 28 | $494 |
| Pfizer | 23 | $351 |
| UCB, Inc. | 16 | $306 |
| Regeneron Healthcare Solutions, Inc. | 8 | $194 |
| Johnson & Johnson | 13 | $194 |
| Lilly USA, LLC | 8 | $135 |
| E.r. Squibb & Sons, L.L.C. | 8 | $122 |
| Genentech USA, Inc. | 5 | $109 |
| Novartis | 3 | $60 |
| GSK | 4 | $57 |
| Radius Health, Inc. | 3 | $56 |
| Sanofi | 3 | $55 |
| Bristol Myers Squibb | 2 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.